(Q39671057)

13 September 2017

title

Targeted nanoparticles deliver siRNA to melanoma (English)

1 reference

13 September 2017

0 references

Yunching Chen

1

0 references

author name string

Surendar R Bathula

series ordinal

2

1 reference

13 September 2017

Qi Yang

series ordinal

3

1 reference

13 September 2017

Leaf Huang

series ordinal

4

1 reference

13 September 2017

language of work or name

English

0 references

publication date

5 August 2010

1 reference

Journal of Investigative Dermatology

13 September 2017

published in

1 reference

13 September 2017

volume

130

1 reference

13 September 2017

issue

12

1 reference

13 September 2017

page(s)

2790-2798

1 reference

The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

Ex vivo and in vivo delivery of anti-tissue factor short interfering RNA inhibits mouse pulmonary metastasis of B16 melanoma cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

Treatment of metastatic malignant melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

Anisamide-targeted stealth liposomes: a potent carrier for targeting doxorubicin to human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

Implications of oxidative stress and cell membrane lipid peroxidation in human cancer (Spain).

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

Inhibition of bcl-2 as cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

Immunostimulation mechanism of LPD nanoparticle as a vaccine carrier.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

The c-Myc target gene network

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

siRNA-based approaches in cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

The correlation between colorectal cancer rates of proliferation and apoptosis and systemic cytokine levels; plus their influence upon survival

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

c-MYC overexpression in Ba/F3 cells simultaneously elicits genomic instability and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

MYC prevents apoptosis and enhances endoreduplication induced by paclitaxel

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

Apoptosis and melanoma: how new insights are effecting the development of new therapies for melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

Blocking c-myc and stat3 by E. coli expressed and enzyme digested siRNA in mouse melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

Capsaicin induced apoptosis of B16-F10 melanoma cells through down-regulation of Bcl-2.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

Strategy for reversing resistance to a single anticancer agent in human prostate and pancreatic carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

Reactive oxygen species (ROS) control the expression of Bcl-2 family proteins by regulating their phosphorylation and ubiquitination

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

Tumor-targeted delivery of siRNA by self-assembled nanoparticles

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

Efficient oncogene silencing and metastasis inhibition via systemic delivery of siRNA.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

Targeting hypoxia-inducible factor-1alpha with Tf-PEI-shRNA complex via transferrin receptor-mediated endocytosis inhibits melanoma growth

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

Role of reactive oxygen species in apoptosis: implications for cancer therapy.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

Galectin-1 knockdown increases sensitivity to temozolomide in a B16F10 mouse metastatic melanoma model

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

Safety and biologic activity of intravenous BCL-2 antisense oligonucleotide (G3139) and taxane chemotherapy in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

MYC oncogenes and human neoplastic disease

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

ROS stress in cancer cells and therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

MDA-MB-435 cells are derived from M14 melanoma cells--a loss for breast cancer, but a boon for melanoma research

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

Tumor regression in mice by delivery of Bcl-2 small interfering RNA with pegylated cationic liposomes

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

The basic biology of malignant melanoma: molecular mechanisms of disease progression and comparative aspects

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

Temozolomide in combination with cisplatin in patients with metastatic melanoma: a phase II trial

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

Reactive oxygen species in cell signaling

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

Reactive oxygen species may have antitumor activity in metastatic melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

The c-myc promoter: still MysterY and challenge

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

WT1 gene silencing by aerosol delivery of PEI-RNAi complexes inhibits B16-F10 lung metastases growth

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.222

7 January 2021

Identifiers

DOI

10.1038/JID.2010.222

1 reference

13 September 2017

1 reference